Healthy subjects
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Males and females aged 18 years or older at the time of informed consent. In principle, those whose fasting blood triglyceride level at the time of screening test is less than 150mg/dL. Those who fully understand the purpose and safety of this research specified in the research cooperation consent form and have obtained consent.
Exclusion criteria
Exclusion criteria: Persons receiving treatment, medication, or lifestyle guidance from a doctor due to dyslipidemia or diabetes. Persons who regularly use medicines, health foods, or supplements that affect blood lipids. Those with serious illnesses, such as diabetes, liver disease, kidney disease, high blood pressure, ischemic heart disease, or digestive system disease, or those with a history of such illnesses. Those taking medicines or supplements that may affect glucose metabolism. Persons who have some kind of disease and are receiving medication and are deemed unsuitable as subjects by the research doctor. Persons whose HIV antigen/antibody, HBs antigen, HCV antibody, or syphilis test result was positive at the time of screening. Persons with obvious abnormalities found in hematological or biochemical tests. Those who are pregnant, wish to become pregnant during the test, or are breastfeeding. Persons who had difficulty collecting blood during the screening test. Persons whose triglyceride delta C3h (estimated TGCmax) is less than 30 mg/dL in the screening test. Persons who may experience allergic symptoms regarding the test noodles (flour, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The area under the curve (AUC, delta AUC) of the postprandial serum triglyceride. The serum triglyceride level C, delta C. The maximum concentration (Cmax, delta Cmax) of the postprandial serum triglyceride. | — |
Countries
Japan
Contacts
General Incorporated Association, Kendai Translational Research Center Clinical Research Department